Trial Profile
A Phase I, Single Center, Placebo-Controlled, Blinded Pilot Study of Ipratropium Bromide in Children Admitted to the Intensive Care Unit With Status Asthmaticus
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Apr 2019
Price :
$35
*
At a glance
- Drugs Ipratropium bromide (Primary) ; Corticosteroid; Salbutamol
- Indications Status asthmaticus
- Focus Therapeutic Use
- 17 Apr 2019 Status changed from recruiting to completed.
- 24 Oct 2017 Planned End Date changed from 1 Sep 2017 to 1 Sep 2018.
- 24 Oct 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Sep 2018.